Hamamatsu Photonics' Danish subsidiary will build a new laser plant in Switzerland and double production capacity for systems used in ophthalmic surgery from the current level.
Hamamatsu Photonics announced that its Danish subsidiary, which operates its laser business, will establish a new plant in Switzerland. The company will significantly increase production capacity for laser systems used in surgeries for conditions such as cataracts, meeting demand in the medical field.
The new plant will have four floors above ground, with total construction costs of approximately CHF 13 million (approximately ¥2.4 billion). Production is scheduled to be relocated from the existing site by the end of 2026, with operations beginning in January 2027.
The new products are laser systems that combine high-precision processing with the suppression of thermal effects. Adoption of laser scalpels for ophthalmic surgery is expected to expand, particularly in the United States and Europe. Hamamatsu Photonics positions this business as a future growth driver and aims to expand into a wide range of applications, including quantum computing and security.